References
-
Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P (2003). The gprotein-coupled 5-htr1a receptor causes suppression of caspase-3 through mapk and protein kinase c
$\alpha$ . BBA-Mol Cell Res, 1640, 85-96. - Akbari A, Razzaghi Z, Homaee F, et al (2011). Parity and breastfeeding are preventive measures against breast cancer in iranian women. Breast Cancer, 18, 51-5. https://doi.org/10.1007/s12282-010-0203-z
- Antonova L, Aronson K, Mueller CR (2011). Stress and breast cancer: from epidemiology to molecular biology. Breast Cancer Res, 13, 208. https://doi.org/10.1186/bcr2836
- Aro AR, Koning HD, Schreck M, et al (2005). Psychological risk factors of incidence of breast cancer: a prospective cohort study in finland. Psychol Med, 35, 1515-21. https://doi.org/10.1017/S0033291705005313
- Cogolludo A, Moreno L, Lodi F, et al. (2006). Serotonin inhibits voltage-gated k+ currents in pulmonary artery smooth muscle cells role of 5-ht2a receptors, Caveolin-1, and KV1. 5 channel internalization. Circ Res, 98, 931-38. https://doi.org/10.1161/01.RES.0000216858.04599.e1
- Donegan WL, Redlich PN (1996). Breast cancer in men. Surg Clin North Am, 76, 343-63. https://doi.org/10.1016/S0039-6109(05)70443-6
- Haghighat S, Akbari M, Ghaffari S, Yavari P (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-28. https://doi.org/10.7314/APJCP.2012.13.11.5525
- Hannon J, Hoyer D (2008). Molecular Biology of 5-HT receptors. Behav Brain Res, 195, 198-213. https://doi.org/10.1016/j.bbr.2008.03.020
- Helmrich SP, Shapiro S, Rosenberg L, et al (1983). Risk factors for breast cancer. Am J Epidemiol, 117, 35-45.
- Herbert TB, Cohen S (1993). Depression and Immunity: A meta-analytic review. Psychol Bull, 113, 472-86. https://doi.org/10.1037/0033-2909.113.3.472
- Iken K, Chheng S, Fargin A, Goulet A-C, Kouassi E (1995). Serotonin upregulates mitogen-stimulated b lymphocyte proliferation through 5-ht1a receptors. Cell Immunol, 163, 1-9. https://doi.org/10.1006/cimm.1995.1092
- Khan NA, Hichami A (1999). Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase c-dependent phospholipase d pathway in human T-cells. Biochem J, 344, 199-204 https://doi.org/10.1042/0264-6021:3440199
- Kopparapu PK, Tinzl M, Anagnostaki L, Persson JL, Dizeyi, N (2013). Expression and localization of serotonin receptors in human breast cancer. Anticancer Res, 33, 363-70.
- Leonard BE (2010). The concept of depression as a dysfunction of the immune system. Curr Immunol Rev, 6, 205-212. https://doi.org/10.2174/157339510791823835
- Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN (1995). Proportion of breast cancer cases in the united states explained by well-established risk factors. J Natl Cancer Inst, 87, 1681-85. https://doi.org/10.1093/jnci/87.22.1681
- Moorman PG, Grubber JM, Millikan RC, Newman B (2003). Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology, 14, 307-14.
- Nazlican E, Akbaba M, Okyay RA (2012). Evaluation of depression in newly diagnosed breast cancer cases in Hatay province of Turkey in 2011. Asian Pac J Cancer Prev, 13, 2557-61. https://doi.org/10.7314/APJCP.2012.13.6.2557
- Persky VW, Kempthorne-Rawson J, Shekelle RB (1987). Personality and risk of cancer: 20-year follow-up of the western electric study. Psychosom Med, 49, 435-49. https://doi.org/10.1097/00006842-198709000-00001
- Pinquart M, Duberstein PR (2010). Depression and cancer mortality: a meta-analysis. Psychol Med, 40, 1797-810 https://doi.org/10.1017/S0033291709992285
- Prelusky D (1996). A study on the effect of deoxynivalenol on serotonin receptor binding in fig brain membranes. J Environ Sci Health B, 31, 1103-17. https://doi.org/10.1080/03601239609373056
- Reiche EMV, Nunes SOV, Morimoto HK (2004). Stress, depression, the immune system, and cancer. Lancet Oncol, 5, 617-25. https://doi.org/10.1016/S1470-2045(04)01597-9
- Schoevers R, Beekman A, Van Tilburg W, et al. (2000). Association of depression and gender with mortality in old age results from the amsterdam study of the elderly (AMSTEL). Br J Psychiatry, 177, 336-42. https://doi.org/10.1192/bjp.177.4.336
- Shariati GR, Ahangari G, Asadi SM, Ahmadkhaniha HR (2009). Expression changes of serotonin receptor gene subtype 5ht3a in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and olanzapin. Iran J Allergy Asthma Immunol, 8, 135-9.
- Siddiqui EJ, Thompson CS, Mikhailidis DP, Mumtaz FH (2005). The role of serotonin in tumour growth. Oncol Rep, 14, 1593-7.
- Soll C, Jang JH, Riener MO, et al. (2009). Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology, 51, 1244-54.
- Sonier B, Arseneault M, Lavigne C, Ouellette RJ, Vaillancourt C (2006). The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochem Biophys Res Commun, 343, 1053-59. https://doi.org/10.1016/j.bbrc.2006.03.080
- Wang PS, Walker AM, Tsuang MT, et al (2001). Antidepressant use and the risk of breast cancer: a non-association. J Clin Epidemiol, 54, 728-34. https://doi.org/10.1016/S0895-4356(00)00354-1
- Webster JI, Tonelli L, Sternberg EM (2002). Neuroendocrine regulation of immunity. Annu Rev Immunol, 20, 125-63. https://doi.org/10.1146/annurev.immunol.20.082401.104914
- Yavuzsen T, Karadibak D, Cehreli R, Dirioz M (2012). Effect of group therapy on psychological symptoms and quality of life in Turkish patients with breast cancer. Asian Pac J Cancer Prev, 13, 5593-97. https://doi.org/10.7314/APJCP.2012.13.11.5593
Cited by
- Dopamine Receptor Gene (DRD1-DRD5) Expression Changes as Stress Factors Associated with Breast Cancer vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10339
- The effects of spiritual intervention and changes in dopamine receptor gene expression in breast cancer patients vol.23, pp.6, 2016, https://doi.org/10.1007/s12282-015-0658-z
- Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness vol.71, pp.4, 2017, https://doi.org/10.1080/08039488.2016.1276624